Skip to Main Content

Latest Internal Medicine News

Immunotherapy Shows Activity Against Brain Metastases Among Certain Patients With NSCLC

Approximately one-quarter of patients with advanced lung cancer develop brain metastases. The standard treatment for these patients — radiation — can sometimes result in significant toxicity. Immunotherapy with checkpoint inhibitors has shown efficacy in various cancers, including lung cancer. Approximately one-quarter of patients with advanced lung cancer develop brain metastases. The standard treatment for these patients — radiation — can sometimes result in significant toxicity. Immunotherapy with checkpoint inhibitors has shown efficacy in various cancers, including lung cancer. However, the activity of immunotherapy in the brain had not been studied extensively.

Source: Healio
Read more